Publications Database

Akhondzadeh S. et al. (2004)

Cyproheptadine in the treatment of autistic disorder: a double-blind placebo-controlled trial.

Journal of Clinical Pharmacy and Therapeutics

29(2), pp.145-150

Read Abstract (New Window)

Anderson L. T. et al. (1984)

Haloperidol in the treatment of infantile autism: effects on learning and behavioral symptoms

American Journal of Psychiatry

141(10), pp. 1195-1202

Read Abstract (New Window)

Anderson L. T. et al. (1989)

The effects of haloperidol on discrimination learning and behavioral symptoms in autistic children.

Journal of Autism and Developmental Disorders

19(2), pp. 227-239

Read Abstract (New Window)

Brasić J. R. (1997)

Hyperkinesias in a prepubertal boy with autistic disorder treated with haloperidol and valproic acid.

Psychology Report

80(1), pp. 163-170

Read Abstract (New Window)

Campbell M. et al. (1978)

A comparison of haloperidol and behavior therapy and their interaction in autistic children.

Journal of the American Academy of Child and Adolescent Psychiatry

17(4), pp. 640-655

Read Abstract (New Window)

Campbell M. et al. (1982)

The effects of haloperidol on learning and behavior in autistic children.

Journal of Autism and Developmental Disorders

12(2), pp. 167-175

Read Abstract (New Window)

Doyle C. A. , McDougle C. J. (2012)

Pharmacotherapy to control behavioral symptoms in children with autism.

Expert Opinion on Pharmacotherapy

13(11), pp. 1615-1629.

Read Abstract (New Window)

Ernst M. et al. (1993)

Plasma beta-endorphin levels, naltrexone, and haloperidol in autistic children.

Psychopharmacology Bulletin

29(2), pp. 221-227

Read Abstract (New Window)

Faretra G. , Dooher L. , Dowling J. (1970)

Comparison of haloperidol and fluphenazine in disturbed children.

American Journal of Psychiatry

126(11), pp. 1670-1673.

Read Abstract (New Window)

Gencer O. et al. (2008)

Comparison of long-term efficacy and safety of risperidone and haloperidol in children and adolescents with autistic disorder : An open label maintenance study.

European Child and Adolescent Psychiatry

17(4), pp. 217-225

Read Abstract (New Window)

Ghaziuddin M. , Tsai L. Y. , Ghaziuddin N. (1991)

Brief report: haloperidol treatment of trichotillomania in a boy with autism and mental retardation.

Journal of Autism and Developmental Disorders

21(3), pp. 365-371

Read Abstract (New Window)

Hamrin V. et al. (2008)

Psychopharmacological treatment of non-comorbid and comorbid pervasive developmental disorder and pediatric bipolar disorder.

Minerva Pediatrics

60(1), pp. 87-101

Read Abstract (New Window)

Hoshino Y. et al. (1979)

Effects of small doses of haloperidol on autistic children.

Fukushima Journal of Medical Science

26(1), pp. 43-54

Malone R. P. et al. (2001)

Olanzapine versus haloperidol in children with autistic disorder: an open pilot study.

Journal of the American Academy of Child and Adolescent Psychiatry

40 pp. 887-894.

Read Abstract (New Window)

Malone R. P. , Waheed A. (2009)

The role of antipsychotics in the management of behavioural symptoms in children and adolescents with autism.

Drugs

69(5), pp. 535-548.

Read Abstract (New Window)

Miral S. et al. (2008)

Risperidone versus haloperidol in children and adolescents with AD: a randomized, controlled, double-blind trial.

European Child and Adolescent Psychiatry

17(1), pp. 1-8.

Read Abstract (New Window)

Ornitz E. M. (1985)

Should autistic children be treated with haloperidol?

American Journal of Psychiatry

142(7), pp. 883-884

Perry R. et al. (1989)

Long-term efficacy of haloperidol in autistic children: Continuous versus discontinuous drug administration.

Journal of the American Academy of Child and Adolescent Psychiatry

28 pp. 87-92

Read Abstract (New Window)

American Society of Health-System Pharmacists (2008)

Haloperidol.

Bethesda, MD: American Society of Health-System Pharmacists

Read Full (New Window)

Posey D. J. et al. (2008)

Antipsychotics in the treatment of autism.

Journal of Clinical Investigation

118(1), pp. 6-14

Read Abstract (New Window) Read Full (New Window)